You may be interested in these additional resources
Art Meets Science: Recruiting for Phase I Oncology Studies
With the shift toward precision oncology, trial eligibility should be based on an individualized approach. As patient selection in phase I trials can have far-reaching effects that impact later studies, sponsors should carefully apply a data-driven approach to defining their target population. Read our blog.
Premier Research to Sponsor BIO International in June 2019
Premier Research is proud to sponsor this year’s BIO International Convention June 3-6, 2019 in Philadelphia, PA. As a co-sponsor of the Orphan & Rare Disease session track, we look forward to continuing the conversation about how far we’ve come in the treatment of these unmet needs—and the work that still needs to be done. Learn more.
Case Study: Recruiting Scarce Patients From a Specific HLA Subgroup
Our patient screening failure rate was close to 70 percent, and then the client made the trial significantly more complex. Our relationships with key opinion leaders in Russia and the ability to respond quickly to a major change of direction helped turn the tide. Learn how.